Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Aadi Bioscience, Inc. (ARPO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/17/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/26/2022 |
SC 13D/A
| Avoro Capital Advisors LLC reports a 14.4% stake in Aadi Bioscience, Inc. |
| 11/12/2021 |
SC 13D/A
| Satter Muneer A reports a 1.8% stake in Aadi Bioscience, Inc. |
| 09/03/2021 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 1.7% stake in AADI BIOSCIENCE, INC. |
| 08/30/2021 |
SC 13D/A
| Avoro Capital Advisors LLC reports a 10.7% stake in Aadi Bioscience, Inc. |
| 11/12/2020 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 11% stake in AERPIO PHARMACEUTICALS, INC. |
| 05/15/2020 |
SC 13D/A
| Novartis Bioventures Ltd reports a 1.6% stake in Aerpio Pharmaceuticals, Inc. |
| 04/22/2020 |
SC 13D/A
| Novartis Bioventures Ltd reports a 7.8% stake in Aerpio Pharmaceuticals, Inc. |
| 06/07/2019 |
SC 13D/A
| Novartis Bioventures Ltd reports a 8.8% stake in Aerpio Pharmaceuticals, Inc. |
| 04/29/2019 |
SC 13D/A
| Novartis Bioventures Ltd reports a 10% stake in Aerpio Pharmaceuticals, Inc. |
| 04/11/2019 |
SC 13D/A
| Novartis Bioventures Ltd reports a 12.1% stake in Aerpio Pharmaceuticals, Inc. |
| 03/28/2019 |
SC 13D/A
| Novartis Bioventures Ltd reports a 13.5% stake in Aerpio Pharmaceuticals, Inc. |
| 01/11/2019 |
SC 13D/A
| Satter Muneer A reports a 13.9% stake in Aerpio Pharmaceuticals, Inc. |
| 10/03/2018 |
SC 13D/A
| Kearny Venture Partners LP reports a 0.1% stake in Aerpio Pharmaceuticals, Inc. |
| 07/09/2018 |
SC 13D/A
| Novartis Bioventures Ltd reports a 15% stake in Aerpio Pharmaceuticals, Inc. |
| 07/03/2018 |
SC 13D/A
| Satter Muneer A reports a 13.1% stake in Aerpio Pharmaceuticals, Inc. |
| 07/02/2018 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 13.4% stake in AERPIO PHARMACEUTICALS, INC. |
|
|